Literature DB >> 11797095

Existence of MHC class I-restricted alloreactive CD4+ T cells reacting with peptide transporter-deficient cells.

H Kobayashi1, S Kimura, N Aoki, K Sato, E Celis, M Katagiri.   

Abstract

It is generally accepted that as the result of positive thymic selection, CD8-expressing T cells recognize peptide antigens presented in the context of MHC class I molecules and CD4-expressing T cells interact with peptide antigens presented by MHC class II molecules. Here we report the generation of TCRalpha/beta(+), CD3(+), CD4(+), CD8(-), MHC class I-restricted alloreactive T-cell clones which were induced using peripheral blood mononuclear cells from healthy individuals following in vitro stimulation with transporter associated with antigen processing (TAP)-deficient cell lines T2. The CD4(+) T-cell clones showed an HLA-A2.1-specific proliferative response against T2 cells which was inhibited by anti-CD3 and anti-CD4 monoclonal antibodies. These results suggest that interaction of the TCR with peptide-bound HLA class I molecules contributes to antigen-specific activation of these co-receptor-mismatched T-cell clones. Antigen recognition by alloreactive MHC class I-restricted CD4(+) T cells was inhibited by removing peptides bound to HLA molecules on T2 cells suggesting that the alloreactive CD4(+) T cells recognize peptides that bind in a TAP-independent manner to HLA-A2 molecules. The existence of such MHC class I-restricted CD4(+) T cells which can recognize HLA-A2 molecules in the absence of TAP function may provide a basis for the development of immunotherapy against TAP-deficient tumor variants which would be tolerant to immunosurveillance by conventional MHC class I-restricted cytotoxic lymphocytes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11797095     DOI: 10.1007/s00251-001-0379-7

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  6 in total

1.  High-affinity human leucocyte antigen class I binding variola-derived peptides induce CD4+ T cell responses more than 30 years post-vaccinia virus vaccination.

Authors:  M Wang; S T Tang; O Lund; M H Dziegiel; S Buus; M H Claesson
Journal:  Clin Exp Immunol       Date:  2009-03       Impact factor: 4.330

2.  Genetic susceptibility to type 1 diabetes in the intracellular pathway of antigen processing - a subject review and cross-study comparison.

Authors:  Charles Sia; Michael Weinem
Journal:  Rev Diabet Stud       Date:  2005-05-10

3.  The role of HLA class I gene variation in autoimmune diabetes.

Authors:  Charles Sia; Michael Weinem
Journal:  Rev Diabet Stud       Date:  2005-08-10

4.  Major histocompatibility complex class I-restricted alloreactive CD4+ T cells.

Authors:  Louise H Boyle; Jane C Goodall; J S Hill Gaston
Journal:  Immunology       Date:  2004-05       Impact factor: 7.397

5.  Probing the effector and suppressive functions of human T cell subsets using antigen-specific engineered T cell receptors.

Authors:  Qi Wan; Lina Kozhaya; Keren Imberg; Frances Mercer; Shi Zhong; Michelle Krogsgaard; Derya Unutmaz
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

6.  A rare population of tumor antigen-specific CD4+CD8+ double-positive αβ T lymphocytes uniquely provide CD8-independent TCR genes for engineering therapeutic T cells.

Authors:  Junko Matsuzaki; Takemasa Tsuji; Thinle Chodon; Courtney Ryan; Richard C Koya; Kunle Odunsi
Journal:  J Immunother Cancer       Date:  2019-01-09       Impact factor: 13.751

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.